HER-2 ultra-low breast cancer: exploring the clinicopathological features and prognosis in a retrospective study

OBJECTIVE: To explore the clinicopathological features of patients with ultra-low expression of human epidermal growth factor 2 (HER-2) in breast cancer and its impact on prognosis METHODS: Data from 1024 patients with primary breast cancer having HER-2 ultra-low expression from January 01, 2018, to...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Jiajie, Zhang, Liqiu, Geng, Cuizhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472273/
https://www.ncbi.nlm.nih.gov/pubmed/37664018
http://dx.doi.org/10.3389/fonc.2023.1210314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472273/
https://www.ncbi.nlm.nih.gov/pubmed/37664018
http://dx.doi.org/10.3389/fonc.2023.1210314

Ejemplares similares